Evidence map›Paper›PMID 35860094›Full record

ArticleAnnals of medicine and surgery (2012)2022

Euglycemic diabetic ketoacidosis in a patient with acute stroke taking sodium glucose co-transporter 2 inhibitor.

Bishnu Deep Pathak, Bishal Dhakal, Ayush Mohan Bhattarai, Binit Upadhaya Regmi, Sujit Kumar Mandal, Prashanta Raj Panta, Suman Khadka, Nabin Simkhada

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Bishnu Deep PathakNepalese Army Institute of Health Sciences, College of Medicine, Kathmandu, Nepal.
Bishal DhakalNepalese Army Institute of Health Sciences, College of Medicine, Kathmandu, Nepal.
Ayush Mohan BhattaraiNepalese Army Institute of Health Sciences, College of Medicine, Kathmandu, Nepal.
Binit Upadhaya RegmiNepalese Army Institute of Health Sciences, College of Medicine, Kathmandu, Nepal.
Sujit Kumar MandalNepalese Army Institute of Health Sciences, College of Medicine, Kathmandu, Nepal.
Prashanta Raj PantaNepalese Army Institute of Health Sciences, College of Medicine, Kathmandu, Nepal.
Suman KhadkaDepartment of Internal Medicine, Nepalese Army Institute of Health Sciences, College of Medicine, Kathmandu, Nepal.
Nabin SimkhadaNepalese Army Institute of Health Sciences, College of Medicine, Kathmandu, Nepal.
Nepalese Army Institute of Health Services · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Diabetic Ketoacidosis is characterized by a triad of metabolic acidosis, hyperglycemia, and ketonemia. It is a medical emergency that needs urgent and aggressive management. In some cases, the blood glucose level may be relatively normal. Such a condition is known as Euglycemic Diabetic Ketoacidosis. Case presentation: We present a case of Euglycemic Diabetic Ketoacidosis, who was initially brought to the emergency room with the features of acute stroke. There was a diagnostic dilemma among the treating physicians due to his relatively normal blood glucose levels while he developed ketoacidosis. Discussion: Presentation of the patients includes similar to DKA such as nausea, vomiting, malaise, fatigue, and Kussmaul's respiration. The diabetic patients under sodium glucose co-transporter-2 inhibitor therapy may develop it under the setting of different precipitating factors like infection, trauma/surgery, strenuous physical exercise, fasting, alcohol intake and acute vascular events. Conclusion: Euglycemic DKA is a rare condition and its diagnosis is a challenging task. So, we should always consider it as a differential whenever any diabetic patient shows with increased anion gap metabolic acidosis with or without typical symptoms and signs. Also, we need to be aware to discontinue of SGLT-2 medication during the time of infection, surgery, severe trauma, acute illness and dehydration in the diabetic patients.

Indexed as

Diabetic ketoacidosisSodium-glucose transporter 2 inhibitorStroke

Identifiers

PMID35860094
PMCPMC9289500
OpenAlexW4283818909

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.